• Javier Fernández, Carles Aracil, Elsa Solà, Germán Soriano, Maria Cinta Cardona, Susanna Coll, Joan Genescà, Manoli Hombrados, Rosa Morillas, Marta Martín-Llahí, Albert Pardo, Jordi Sánchez, Victor Vargas, Xavier Xiol, and Pere Ginès.
• Liver Unit, Hospital Clínic, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, CIBERehd, Barcelona, España.
• Gastroent Hepat Barc. 2016 Nov 1; 39 (9): 607-626.

AbstractCirrhotic patients often develop severe complications requiring ICU admission. Grade III-IV hepatic encephalopathy, septic shock, acute-on-chronic liver failure and variceal bleeding are clinical decompensations that need a specific therapeutic approach in cirrhosis. The increased effectiveness of the treatments currently used in this setting and the spread of liver transplantation programs have substantially improved the prognosis of critically ill cirrhotic patients, which has facilitated their admission to critical care units. However, gastroenterologists and intensivists have limited knowledge of the pathogenesis, diagnosis and treatment of these complications and of the prognostic evaluation of critically ill cirrhotic patients. Cirrhotic patients present alterations in systemic and splanchnic hemodynamics, coagulation and immune dysfunction what further increase the complexity of the treatment, the risk of developing new complications and mortality in comparison with the general population. These differential characteristics have important diagnostic and therapeutic implications that must be known by general intensivists. In this context, the Catalan Society of Gastroenterology and Hepatology requested a group of experts to draft a position paper on the assessment and treatment of critically ill cirrhotic patients. This article describes the recommendations agreed upon at the consensus meetings and their main conclusions.Copyright © 2015 Elsevier España, S.L.U. y AEEH y AEG. All rights reserved.

46 keywords...

hide…